169 related articles for article (PubMed ID: 4588817)
21. The UGDP--tolbutamide and mortality.
Knowles HC
Horm Metab Res; 1974; Suppl 4():186-8. PubMed ID: 4609432
[No Abstract] [Full Text] [Related]
22. Diabetic hearts and biguanides.
Biron P
Can Med Assoc J; 1975 Aug; 113(3):175-6. PubMed ID: 166752
[No Abstract] [Full Text] [Related]
23. [Oral antidiabetic drugs].
Z Allgemeinmed; 1975 Feb; 51(5):235. PubMed ID: 1130116
[No Abstract] [Full Text] [Related]
24. [Are hypoglycemic sulfonamides dangerous?].
Aubertin MJ
Bord Med; 1972 Nov; 5(17):2287-90. PubMed ID: 4571486
[No Abstract] [Full Text] [Related]
25. [Tolbutamide and coronary heart disease].
Paasikivi J
Duodecim; 1971; 87(21):1405-8. PubMed ID: 5114598
[No Abstract] [Full Text] [Related]
26. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
Tattersall RB
Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
[No Abstract] [Full Text] [Related]
27. [Increased risk of cardiovascular complications with oral hypoglycemic agents?].
Mueller R
Acta Diabetol Lat; 1970; 7(5):805-23. PubMed ID: 4949515
[No Abstract] [Full Text] [Related]
28. [Attack after oral antidiabetics].
Frey H
Tidsskr Nor Laegeforen; 1970 Nov; 90(22):2097-8. PubMed ID: 5479224
[No Abstract] [Full Text] [Related]
29. Report of the Committee for the Assessment of Biometric Aspects of Controlled Trials of Hypoglycemic Agents.
JAMA; 1975 Feb; 231(6):583-608. PubMed ID: 1089822
[No Abstract] [Full Text] [Related]
30. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results.
Meinert CL; Knatterud GL; Prout TE; Klimt CR
Diabetes; 1970; 19():Suppl:789-830. PubMed ID: 4926376
[No Abstract] [Full Text] [Related]
31. Farewell to phenformin for treating diabetes mellitus.
Williams RH; Palmer JP
Ann Intern Med; 1975 Oct; 83(4):567-8. PubMed ID: 1166991
[No Abstract] [Full Text] [Related]
32. Editorials: Statistical problems in clinical trials: the UGDP study revisited.
Schor SS
Am J Med; 1973 Dec; 55(6):727-32. PubMed ID: 4584989
[No Abstract] [Full Text] [Related]
33. Management of adult-onset diabetes. The impact of the University Group Diabetes Program.
Goetz FC
Postgrad Med; 1972 Jul; 52(1):63-8. PubMed ID: 5067890
[No Abstract] [Full Text] [Related]
34. [Evaluation of oral hypoglycemic agents following the University Group of Diabetes Program].
Sasaki A
Nihon Rinsho; 1977 Feb; 35(2):317-23. PubMed ID: 558370
[No Abstract] [Full Text] [Related]
35. Controversy over study of diabetes drugs continues for nearly a decade.
Kolata GB
Science; 1979 Mar; 203(4384):986-90. PubMed ID: 370980
[No Abstract] [Full Text] [Related]
36. [Are oral antidiabetics ineffective-or even dangerous? The "University Group Diabetes Program" (UGDP) as basis for a controversial discussion on the therapy of diabetes in the aged].
Teuscher A
Schweiz Med Wochenschr; 1972 Jun; 102(24):848-55. PubMed ID: 5033623
[No Abstract] [Full Text] [Related]
37. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results.
Knatterud GL; Meinert CL; Klimt CR; Osborne RK; Martin DB
JAMA; 1971 Aug; 217(6):777-84. PubMed ID: 4935344
[No Abstract] [Full Text] [Related]
38. [Clinical testing of Tolbutaphen in the treatment of adult diabetes].
Schneider J; Kaffarnik H
Z Allgemeinmed; 1975 Jan; 51(2):74-5. PubMed ID: 766424
[No Abstract] [Full Text] [Related]
39. An historical view of the medical-social aspects of the UGDP.
Knowles HC
Trans Am Clin Climatol Assoc; 1977; 88():150-6. PubMed ID: 898533
[No Abstract] [Full Text] [Related]
40. The University Group Diabetes Program. A further statistical analysis of the mortality findings.
Cornfield J
JAMA; 1971 Sep; 217(12):1676-87. PubMed ID: 4937386
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]